BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32767242)

  • 21. Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway.
    Duan X; Zhou Z; Jia SF; Colvin M; Lafleur EA; Kleinerman ES
    Clin Cancer Res; 2004 Jan; 10(2):777-83. PubMed ID: 14760101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy in osteosarcoma.
    O'Farrill JS; Gordon N
    Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.
    Tian H; Yao ST; Yang NN; Ren J; Jiao P; Zhang X; Li DX; Zhang GA; Xia ZF; Qin SC
    Sci Rep; 2017 Aug; 7(1):7333. PubMed ID: 28779128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.
    Wang M; Su P
    Syst Biol Reprod Med; 2018 Apr; 64(2):93-102. PubMed ID: 29299971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
    Ratti C; Botti L; Cancila V; Galvan S; Torselli I; Garofalo C; Manara MC; Bongiovanni L; Valenti CF; Burocchi A; Parenza M; Cappetti B; Sangaletti S; Tripodo C; Scotlandi K; Colombo MP; Chiodoni C
    Clin Cancer Res; 2017 Sep; 23(17):5149-5161. PubMed ID: 28600479
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
    Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
    Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of FAS Receptor Methylation in Osteosarcoma Metastasis.
    Sun JM; Chow WY; Xu G; Hicks MJ; Nakka M; Shen J; Ng PKS; Taylor AM; Yu A; Farrar JE; Barkauskas DA; Gorlick R; Guidry Auvil JM; Gerhard D; Meltzer P; Guerra R; Man TK; Lau CC; On Behalf Of The Target Osteosarcoma Consortium
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.
    Huang G; Koshkina NV; Kleinerman ES
    Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
    Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
    Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Chiou JT; Wang LJ; Lee YC; Chang LS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway.
    Li Z; Xu Q; Peng H; Cheng R; Sun Z; Ye Z
    Int Immunopharmacol; 2011 Apr; 11(4):496-503. PubMed ID: 21238618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.
    Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF
    Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Xie T; Cai Y; Wang Z; Jiang B
    Carcinogenesis; 2014 Jan; 35(1):173-83. PubMed ID: 23929433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress.
    Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS
    Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
    Duan X; Jia SF; Koshkina N; Kleinerman ES
    Cancer; 2006 Mar; 106(6):1382-8. PubMed ID: 16453328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
    Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation.
    Faletti L; Peintner L; Neumann S; Sandler S; Grabinger T; Mac Nelly S; Merfort I; Huang CH; Tschaharganeh D; Kang TW; Heinzmann F; D'Artista L; Maurer U; Brunner T; Lowe S; Zender L; Borner C
    Cell Death Dis; 2018 Sep; 9(9):909. PubMed ID: 30185788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.